RSP US
RSP ETF: How Invesco S&P 500® Equal Weight ETF Works
Last updated: 2026-10-03
Overview
The Invesco S&P 500 Equal Weight ETF (RSP) offers Australian investors a way to research US large-company equities through an equal-weight approach. Its reported returns are 11.52% year to date and 14.86% over one year, while the net expense ratio is 0.2%. As a US-domiciled fund traded in US dollars, it also brings currency considerations for Australian investors.
Category
RSP combines large US company exposure with an equal-weight portfolio design. Rather than letting the biggest companies account for most of the portfolio, the approach spreads weight more evenly across constituents. This creates a distinct alternative within the broad US equity category, but does not guarantee lower volatility or better returns.
Equal weighting offers a different way to participate in the US large-company market: it reduces the influence of the very largest constituents and gives smaller constituents within the portfolio a comparatively greater role. That can lead to different sector and company exposures, and different performance, from market-cap-weighted US equity funds.
Key facts
- Ticker
- RSP
- Exchange
- US
- ISIN
- US46137V3574
- Category / focus
- Large Blend
- Provider
- Invesco
- Domicile
- United States
- Currency
- USD
- Inception date
- 2003-04-24
- Use of income
- NA
- UCITS
- No
- Holdings count
- 50
Costs
- TER
- 0.20%
- Net expense ratio
- 0.20%
- AUM
- 96.6B
The supplied net expense ratio is 0.2%. The reported dividend yield is 1.46%; this is not a fixed payment and can change.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Performance
- YTD
- 11.5%
- 1 year
- 14.9%
- 3 years
- 15.7%
- 5 years
- 8.3%
- 10 years
- 11.6%
- Dividend yield
- 1.46%
- Top 10 concentration
- 2.6%
Holdings
-
Moderna Inc0.30%
-
Everpure, Inc.0.27%
-
Illumina Inc0.27%
-
Crowdstrike Holdings Inc0.25%
-
Revvity Inc.0.25%
-
Agilent Technologies Inc0.25%
-
Mettler-Toledo International Inc0.24%
-
Datadog Inc0.24%
-
Intuitive Surgical Inc0.24%
-
Palo Alto Networks Inc0.24%
Weights are percentages of the fund; bars use a 0–100% scale. Displayed entries may not cover the whole portfolio.
The portfolio contains 50 holdings, with reported exposure spanning technology, healthcare, industrials and financial services. The largest reported positions are modest in size: Moderna is 0.297%, Everpure is 0.272% and Illumina is 0.27%. This gives the fund a markedly distributed set of individual company weights, though it remains concentrated in US equities overall.
Regions
-
North America98.7%
-
Europe Developed0.6%
-
Asia Emerging0.2%
-
Latin America0.2%
-
United Kingdom0.2%
-
Japan0.0%
-
Australasia0.0%
-
Asia Developed0.0%
-
Europe Emerging0.0%
-
Africa/Middle East0.0%
Weights are percentages of the fund; bars use a 0–100% scale. Displayed entries may not cover the whole portfolio.
Asset allocation
-
Stock US98.3%
-
Stock non-US1.3%
-
Cash0.5%
-
Bond0.0%
-
Other0.0%
-
NotClassified0.0%
Weights are percentages of the fund; bars use a 0–100% scale. Displayed entries may not cover the whole portfolio.
Sectors
-
Technology17.9%
-
Industrials15.2%
-
Financial Services13.6%
-
Healthcare12.5%
-
Consumer Cyclicals10.7%
-
Consumer Defensive6.4%
-
Real Estate5.9%
-
Utilities5.8%
-
Energy4.1%
-
Communication Services4.0%
Weights are percentages of the fund; bars use a 0–100% scale. Displayed entries may not cover the whole portfolio.
Risks
Who it may suit
RSP may interest investors researching broad exposure to large US companies who want an equal-weight approach rather than allowing the largest companies to dominate portfolio weight. It is a US-domiciled, US-dollar fund, so Australian investors should also consider currency exposure and how the fund fits their overall portfolio.
Key risks
RSP remains exposed to share-market declines and the fortunes of US companies; equal weighting does not remove market risk. Its allocation can also differ meaningfully from market-cap-weighted funds, including through sector exposure. For Australian investors, US-dollar exposure adds currency risk, and the reported dividend yield may vary over time.
FAQ
What does the Invesco S&P 500 Equal Weight ETF focus on?
RSP offers exposure to large US companies using an equal-weight approach. Its portfolio has 50 holdings, and its largest reported holding, Moderna, represents 0.297% of assets.
What is RSP’s management fee?
The supplied net expense ratio is 0.2%.
What should Australian investors consider?
RSP is a US-domiciled fund traded in US dollars. Australian investors therefore face currency movements between the US dollar and Australian dollar, as well as changes in the value of the underlying shares.
*This content is aimed to provide general information only, and does not take your personal objectives, financial situation or needs into account.
